Capillary Biomedical is a medical device startup developing technologies for diabetes management. We aim to dramatically simplify glucose monitoring and insulin delivery, reducing the burden on both patients and the overall healthcare system. Our ultimate goal is a fully-implantable automated insulin delivery system consisting of an long-term continuous glucose monitor, insulin infusion pump and closed-loop control algorithm capable of automatically managing blood glucose.

1M+

Over 1 million insulin pump users worldwide

120+

Patients insert over 120 catheters each year

$2.7B+

Over $2.7 billion spent on insulin pump therapy

More than 1,000,000 people with diabetes on insulin pump therapy are required to change their insulin infusion catheter every two to three days.

“The type 1 diabetes community will greatly benefit from next-generation devices that help maintain glucose control safely and conveniently. We believe advancing infusion set technology will improve those devices and the overall quality of life for people living with T1D.”

 

Aaron Kowalski, JDRF Chief Mission Officer and Vice President of Research.

Find out more

Continuous Subcutaneous Insulin Infusion (CSII) Catheter: From Bench to Bedside

Our goal is to develop an optimized infusion catheter that will allow people with diabetes who use insulin pumps to receive more consistent and reliable continuous subcutaneous insulin infusion (CSII) therapy.

Discover More

Research Collaboration and Funding

Capillary Biomedical thanks our leading research collaboration and funding partners.

The Sidney Kimmel Medical College of Thomas Jefferson University

Capillary Biomedical licenses intellectual property from Thomas Jefferson University and collaborates on CSII catheter development.

Pioneering Research Funding Collaborations for Artificial Pancreas Technology

Capillary Biomedical is supported with funding from JDRF, the leading global organization funding type 1 diabetes research.

Supporting Innovative Research in Diabetes Science and Technology

Capillary Biomedical has been awarded an SBIR grant from the National Institute of Diabetes and Digestive and Kidney Diseases.

We’d love to hear from you. Click below to leave your information.

Contact Us Now